CRMO- CLINICAL RESEARCH MANAGEMENT OFFICE
CRMO- CLINICAL RESEARCH MANAGEMENT OFFICE
批准号:
8114088
负责人:
Edward P Gelmann
金额:
$29.01万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdministratorAdverse eventAmendmentBioinformaticsBiostatistics Shared ResourceBudgetsCancer CenterCancer Center Support GrantClinicalClinical DataClinical ResearchClinical Research AssociateClinical TrialsClinical Trials Informatics SystemCommunicationConduct Clinical TrialsConsent FormsDataDatabasesDiagnostic and Statistical ManualDistrict of ColumbiaDocumentationEnsureFundingGoalsGrantGuidelinesHeadHerbert Irving Comprehensive Cancer CenterIndustryInformaticsInformation SystemsInternetMalignant NeoplasmsMediationMedical centerModelingMonitorNursing ResearchOffice ManagementOperations ResearchPeer ReviewPeer Review GrantsPharmaceutical PreparationsProceduresProcessProtocols documentationQuality ControlReactionReportingResearchResearch ActivityResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch ProposalsResource SharingSouthwest Oncology GroupSupervisionTrainingUniversitiesWorkdata managementdrug developmentexperiencememberoperationquality assuranceweb site
中文摘要
临床研究管理办公室(CRMO)为开展临床研究提供基础设施。
研究在CCCC。CRMO的职能包括:
通过维持行政和试验管理,促进临床研究的开展
操作,
与生物信息学密切合作,确保临床信息系统的最佳运行
数据库,以及
提供与监管和赞助机构的接口。
为了实现这些目标,CRMO有四个办公室,研究护理,数据管理,研究
运营和监管管理以及数据应用。经验丰富的高级管理人员领导每个
四个办公室的负责人和前三个办公室的负责人向研究业务署长报告。的
研究护理办公室和数据管理办公室负责分配、监督,
培训了12名研究护士和28名数据管理员和临床研究助理,
CIMCC临床试验。数据管理办公室还负责审计合规性和质量
保证。研究运营和监管管理办公室,有一名主管和一名
7名工作人员,维护提交给CRMO的每份方案的档案,提交方案,修正案,年度
审查和药物不良反应报告给IRB和PRMC,
为调查人员和工作人员在密码保护的网站上发布了一份协议。该办公室还负责
监督CRMO的质量控制和新程序的实施。数据应用
该小组共同向CRMO主任和生物信息学主任报告,
信息学,包括实施和管理Velos,一个临床试验信息学系统
与CaBIG兼容。CRMO与议定书审查和监测委员会密切合作
(PRMC),与研究者,并与生物统计共享资源,使高效,无缝,
负责癌症中心的临床试验管理。CRMO的预计业务预算
是517,204美元,其中我们要求CCSG提供249,084美元。
英文摘要
The Clinical Research Management Office (CRMO) provides infrastructure for the conduct of clinical
research at the HICCC. The functions of the CRMO include:
¿ Facilitating the conduct of clinical research by maintaining the administrative and trial management
operations,
¿ Working closely with Bioinformatics to ensure the optimal operation of clinical information systems
and databases, and
¿ Providing an interface with regulatory and sponsoring agencies.
To accomplish these goals, the CRMO has four offices, Research Nursing, Data Management, Research
Operations and Regulatory Management, and Data Applications. Experienced senior managers head each
of the four offices and the heads of the first three report to the Administrator for Research Operations. The
Offices of Research Nursing and of Data Management are responsible for the assignment, supervision,
and training of 12 research nurses and 28 data managers and clinical research associates who staff
HICCC clinical trials. The Office of Data Management is also responsible for audit compliance and quality
assurance. The office of Research Operations and Regulatory Management, with a supervisor and a
staff of 7, maintains files on each protocol submitted to the CRMO, submits protocols, amendments, annual
reviews and adverse drug reaction reports to the IRB and PRMC and maintains current copies of open
protocols on a password protected website for investigators and staff. The office is also responsible for
oversight of quality control of the CRMO and implementation of new procedures. The Data Applications
Group reports jointly to the Director of the CRMO and to the Director of Bioinformatics and handles the
informatics that includes the implementation and management of Velos, a clinical trials informatics system
compatible with CaBIG. The CRMO works closely with the Protocol Review and Monitoring Committee
(PRMC), with investigators, and with the Biostatistics Shared Resource to bring efficient, seamless and
responsible clinical trials management to the Cancer Center. The projected operating budget of the CRMO
is $517,204, of which we are requesting $249,084 from the CCSG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DYRK1B Inhibition for Prostate Cancer
-
批准号:10665942
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2023
-
负责人:Edward P Gelmann
-
依托单位:
CRMO- CLINICAL RESEARCH MANAGEMENT OFFICE
-
批准号:8375790
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2012
-
负责人:Edward P Gelmann
-
依托单位:
Role of the DNA Damage Response in Prostate Cancer Initiation
-
批准号:8555289
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2011
-
负责人:Edward P Gelmann
-
依托单位:
CRMO- CLINICAL RESEARCH MANAGEMENT OFFICE
-
批准号:7669945
-
项目类别:
-
资助金额:$17.58万
-
财政年份:2008
-
负责人:Edward P Gelmann
-
依托单位:
PROTOCOL SPECIFIC RESEARCH RESOURCE
-
批准号:7669948
-
项目类别:
-
资助金额:$6.59万
-
财政年份:2008
-
负责人:Edward P Gelmann
-
依托单位:
Beta Catenin in Prostate Cancer
-
批准号:6508758
-
项目类别:
-
资助金额:$22.12万
-
财政年份:2002
-
负责人:Edward P Gelmann
-
依托单位:
Beta Catenin in Prostate Cancer
-
批准号:6897506
-
项目类别:
-
资助金额:$22.12万
-
财政年份:2002
-
负责人:Edward P Gelmann
-
依托单位:
Beta Catenin in Prostate Cancer
-
批准号:6779148
-
项目类别:
-
资助金额:$22.12万
-
财政年份:2002
-
负责人:Edward P Gelmann
-
依托单位:
Beta Catenin in Prostate Cancer
-
批准号:6611392
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2002
-
负责人:Edward P Gelmann
-
依托单位:
BETA CATENIN IN PROSTATE CANCER
-
批准号:6378100
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2000
-
负责人:Edward P Gelmann
-
依托单位:
BETA CATENIN IN PROSTATE CANCER
-
批准号:6190700
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2000
-
负责人:Edward P Gelmann
-
依托单位:
GENETIC POLYMORPHISM IN PROSTATE CANCER
-
批准号:6178504
-
项目类别:
-
资助金额:$20.55万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
APOPTOSIS IN PROSTATE CANCER
-
批准号:2737385
-
项目类别:
-
资助金额:$19.2万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
Genetic Polymorphism in Prostate Cancer
-
批准号:6796723
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
GENETIC POLYMORPHISM IN PROSTATE CANCER
-
批准号:2861411
-
项目类别:
-
资助金额:$20.74万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
Genetic Polymorphism in Prostate Cancer
-
批准号:6926186
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
APOPTOSIS IN PROSTATE CANCER
-
批准号:6342125
-
项目类别:
-
资助金额:$19.32万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
APOPTOSIS IN PROSTATE CANCER
-
批准号:6137704
-
项目类别:
-
资助金额:$18.91万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
GENETIC POLYMORPHISM IN PROSTATE CANCER
-
批准号:6382305
-
项目类别:
-
资助金额:$20.89万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
Genetic Polymorphism in Prostate Cancer
-
批准号:7066529
-
项目类别:
-
资助金额:$16.59万
-
财政年份:1999
-
负责人:Edward P Gelmann
-
依托单位:
海外基金